Author

V. Parreno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Bok· 2 shared A. Bonnyman· 1 shared A. J. Auguste· 1 shared A. M. Biedermann· 1 shared A. Wigdorovitz· 1 shared C. A. Whittaker· 1 shared C. Vega· 1 shared D. A. Militello· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Bok

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants

M. F. Pavan, M. Bok, R. Betanzos San Juan, J. P. Malito, G. A. Marcoppido, D. R. Franco, D. A. Militello, J. M. Schammas, S. Bari, W. B. Stone, K. Lopez, D. Porier, J. Muller, A. J. Auguste, L. Yuan, , L. I. Ibanez

This study develops nanobodies against SARS-CoV-2 that neutralize multiple variants and reduce viral load in the brain of infected mice.

bioRxiv · Mar 14, 2023 · PreprintImmunology

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus

N. C. Dalvie, J. R. Brady, L. E. Crowell, M. K. Tracey, A. M. Biedermann, K. Kaur, J. M. Hickey, D. L. Kristensen, A. Bonnyman, S. A. Rodriguez-Aponte, C. A. Whittaker, M. Bok, C. Vega, T. Mukhopadhyay, S. B. Joshi, , J. C. Love

The paper engineers subunit antigens to improve vaccine manufacturing by reducing variants and enabling single-process production of a trivalent rotavirus vaccine.

bioRxiv · Nov 20, 2020Bioengineering